RESUMO
Alzheimer's disease (AD) remains an incurable neurodegenerative condition that poses a threat to humanity. Immune signaling in the brain, particularly the NLR family pyrin domain containing 3 (NLRP3), is currently targeted for AD treatment. Based on the crystal structure of the NACHT domain of NLRP3 and its renowned inhibitor MCC950, we designed and synthesized nineteen sulfonylurea compounds and evaluated their capacity to inhibit caspase-1 and interleukin-1ß (IL-1ß). Of these, nine were selected for measuring their IC50 for caspase-1 and cytotoxicity analysis. Finally, three compounds were chosen to assess their inhibitory effect on IL-1ß in mice. The results showed that compound 5m had a superior ability to reduce IL-1ß levels in the brain compared to MCC950 at a lower dosing concentration, indicating that 5m has the potential to penetrate the blood-brain barrier (BBB) and inhibit inflammation both in vitro and in vivo. Docking studies of compound 5m on NLRP3 revealed a binding mode similar to MCC950. These findings suggest that compound 5m holds promise as an NLRP3 inhibitor for AD treatment.
Assuntos
Doença de Alzheimer , Indenos , Animais , Camundongos , Doença de Alzheimer/tratamento farmacológico , Caspases , Furanos/farmacologia , Furanos/uso terapêutico , Inflamassomos/metabolismo , Interleucina-1beta/metabolismo , Proteína 3 que Contém Domínio de Pirina da Família NLR/metabolismo , Sulfonamidas/farmacologia , Sulfonamidas/uso terapêutico , Compostos de Sulfonilureia/farmacologia , Compostos de Sulfonilureia/uso terapêutico , Naftalenos/farmacologia , Naftalenos/uso terapêuticoRESUMO
Herbicide resistance is a worldwide concern for weed control. Cucumis melo L. var. agrestis Naud. (C. melo) is an annual trailing vine weed that is commonly controlled by nicosulfuron, acetolactate synthase (ALS)-inhibiting herbicides. However, long-term use of this herbicide has led to the emergence of resistance and several nicosulfuron resistant populations of C. melo have been found. Here we identified a resistant (R) C. melo population exhibiting 7.31-fold resistance to nicosulfuron compared with a reference sensitive (S) population. ALS gene sequencing of the target site revealed no amino acid substitution in R plants, and no difference in enzyme activity, as shown by ALS activity assays in vitro. ALS gene expression was not significantly different before and after the application of nicosulfuron. Pretreatment with the cytochrome P450 monooxygenase (P450) inhibitor malathion reduced nicosulfuron resistance in the R population. RNA-Seq transcriptome analysis was used to identify candidate genes that may confer metabolic resistance to nicosulfuron. We selected genes with annotations related to detoxification functions. A total of 20 candidate genes (7 P450 genes, 1 glutathione S-transferase (GST) gene, 2 ATP-binding cassette (ABC) transporters, and 10 glycosyltransferase (GT)) were identified; 12 of them (7 P450s, 1 GST, 2 ABC transporters, and 2 GTs) were demonstrated significantly differential expression between R and S by quantitative real-time RT-PCR (qRT-PCR). Our findings revealed that the resistance mechanism in C. melo was nontarget-site based. Our results also provide a valuable resource for studying the molecular mechanisms of weed resistance.
Assuntos
Acetolactato Sintase , Cucumis melo , Resistência a Herbicidas , Herbicidas , Piridinas , Compostos de Sulfonilureia , Resistência a Herbicidas/genética , Compostos de Sulfonilureia/farmacologia , Herbicidas/farmacologia , Herbicidas/toxicidade , Acetolactato Sintase/genética , Acetolactato Sintase/metabolismo , Cucumis melo/genética , Cucumis melo/efeitos dos fármacos , Piridinas/farmacologia , RNA-Seq , Perfilação da Expressão Gênica , Malation/farmacologia , Regulação da Expressão Gênica de Plantas/efeitos dos fármacos , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismoRESUMO
Eriochloa villosa (Thunb.) Kunth is a troublesome weed widely distributed in maize (Zea mays L.) fields in Northeast China. Many populations of E. villosa have evolved resistance to nicosulfuron herbicides, which inhibit acetolactate synthase (ALS). The objectives of this research were to confirm that E. villosa is resistant to nicosulfuron and to investigate the basis of nicosulfuron resistance. Whole-plant dose-response studies revealed that the R population had not developed a high level of cross-resistance and exhibited greater resistant (25.62-fold) to nicosulfuron than that of the S population and had not yet developed a high level of cross-resistance. An in vitro ALS activity assay demonstrated that the I50 of nicosulfuron was 6.87-fold greater in the R population than the S population. However, based on ALS gene sequencing, the target ALS gene in the R population did not contain mutations. Quantitative real-time polymerase chain reaction (qRT-PCR) revealed that ALS gene expression between the R and S populations was significantly different after nicosulfuron application, but no differences were observed in the gene copy number. After the cytochrome P450 inhibitor malathion or the GST inhibitor NBD-Cl was applied, the resistant E. villosa population exhibited increased sensitivity to nicosulfuron. Based on the activities of GSTs and P450s, the activities of the R population were greater than those of the S population after nicosulfuron application. This is the first report that the resistance of E. villosa to ALS inhibitors results from increased target gene expression and increased metabolism. These findings provide a theoretical foundation for the effective control of herbicide-resistant E. villosa.
Assuntos
Acetolactato Sintase , Resistência a Herbicidas , Herbicidas , Piridinas , Compostos de Sulfonilureia , Compostos de Sulfonilureia/farmacologia , Acetolactato Sintase/genética , Acetolactato Sintase/metabolismo , Acetolactato Sintase/antagonistas & inibidores , Resistência a Herbicidas/genética , Herbicidas/farmacologia , Piridinas/farmacologia , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Regulação da Expressão Gênica de Plantas/efeitos dos fármacos , Poaceae/genética , Poaceae/efeitos dos fármacosRESUMO
Ammannia auriculata Willd. is a noxious broadleaf weed, commonly infesting rice ecosystems across southern China. A putative resistant A. auriculata population (AHSC-5) was sampled from a rice field of Anhui Province, where bensulfuron-methyl (BM) was unable to control its occurrence. This study aimed to determine the sensitivities of the AHSC-5 population to common-use herbicides, and to investigate the underlying resistance mechanisms. The bioassays showed that the AHSC-5 population was 138.1-fold resistant to BM, compared with the susceptible population (JSGL-1). Pretreatment of malathion reduced the resistance index to 19.5. ALS sequencing revealed an Asp376Glu substitution in the AHSC-5 population, and in vitro ALS activity assays found that 50% activity inhibition (I50) of BM in AHSC-5 was 75.4 times higher than that of JSGL-1. Moreover, the AHSC-5 population displayed cross-resistance to pyrazosulfuron-ethyl (10.6-fold), bispyribacsodium (3.6-fold), and imazethapyr (2.2-fold), and was in the process of evolving multiple resistance to synthetic auxin herbicides fluroxypyr (2.3-fold) and florpyrauxifen-benzyl (3.1-fold). This study proved the BM resistance in A. auriculata caused by the Asp376Glu mutation and P450-regulated metabolism. This multi-resistant population can still be controlled by penoxsulam, MCPA, bentazone, and carfentrazone-ethyl, which aids in developing targeted and effective weed management strategies.
Assuntos
Acetolactato Sintase , Sistema Enzimático do Citocromo P-450 , Resistência a Herbicidas , Herbicidas , Acetolactato Sintase/genética , Acetolactato Sintase/antagonistas & inibidores , Herbicidas/farmacologia , Resistência a Herbicidas/genética , Sistema Enzimático do Citocromo P-450/genética , Sistema Enzimático do Citocromo P-450/metabolismo , Malation/farmacologia , Compostos de Sulfonilureia/farmacologia , Plantas Daninhas/efeitos dos fármacos , Plantas Daninhas/genética , Substituição de AminoácidosRESUMO
Long-lasting hyperglycemia can potentially cause damage to organs such as the kidneys, liver and pancreas. Glimepiride (GLIM), as a drug of choice in the treatment of diabetes mellitus (DM), has the risk of decreasing the functioning of organs such as the kidneys, liver and pancreas. Black rice bran ethanol extract (EEBRB) with antioxidant content has been shown to protect the kidney, liver and pancreas organs. The aim of this study was to establish the effect of EEBRB on lowering fasting blood glucose (FBG) and protecting several organs after GLIM administration in alloxan (ALX)-induced hyperglycemic rats. A total of 20 rats were divided into 4 groups and treated for 21 days treatments using following preparations: normal control (NC), diabetic group (DC), GLIM 1 mg/ kgBW and combination of glimepiride 1mg/kgBW and EEBRB 50 mg/KgBW (GLBR). The results showed that the GLBR was able to lower blood glucose levels back to normal (<126 mg/dL) and protect kidney, liver and pancreas cells by increasing the amount in normal cells.
Assuntos
Glicemia , Diabetes Mellitus Experimental , Hipoglicemiantes , Rim , Fígado , Oryza , Pâncreas , Extratos Vegetais , Compostos de Sulfonilureia , Animais , Compostos de Sulfonilureia/farmacologia , Extratos Vegetais/farmacologia , Extratos Vegetais/isolamento & purificação , Rim/efeitos dos fármacos , Rim/metabolismo , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Oryza/química , Fígado/efeitos dos fármacos , Fígado/metabolismo , Hipoglicemiantes/farmacologia , Hipoglicemiantes/isolamento & purificação , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Experimental/sangue , Diabetes Mellitus Experimental/induzido quimicamente , Pâncreas/efeitos dos fármacos , Pâncreas/metabolismo , Pâncreas/patologia , Masculino , Ratos , Etanol/química , Ratos WistarRESUMO
Diabetes mellitus is characterized by insulin resistance and ß-cell failure. The latter involves impaired insulin secretion and ß-cell dedifferentiation. Sulfonylurea (SU) is used to improve insulin secretion in diabetes, but it suffers from secondary failure. The relationship between SU secondary failure and ß-cell dedifferentiation has not been examined. Using a model of SU secondary failure, we have previously shown that functional loss of oxidoreductase Cyb5r3 mediates effects of SU failure through interactions with glucokinase. Here we demonstrate that SU failure is associated with partial ß-cell dedifferentiation. Cyb5r3 knockout mice show more pronounced ß-cell dedifferentiation and glucose intolerance after chronic SU administration, high-fat diet feeding, and during aging. A Cyb5r3 activator improves impaired insulin secretion caused by chronic SU treatment, but not ß-cell dedifferentiation. We conclude that chronic SU administration affects progression of ß-cell dedifferentiation and that Cyb5r3 activation reverses secondary failure to SU without restoring ß-cell dedifferentiation.
Assuntos
Citocromo-B(5) Redutase , Diabetes Mellitus Tipo 2 , Resistência à Insulina , Células Secretoras de Insulina , Animais , Camundongos , Desdiferenciação Celular , Diabetes Mellitus Tipo 2/tratamento farmacológico , Insulina/farmacologia , Compostos de Sulfonilureia/farmacologia , Citocromo-B(5) Redutase/genética , Citocromo-B(5) Redutase/metabolismoRESUMO
Nicosulfuron-resistant biotype (R) and -sensitive biotype (S) Amaranthus retroflexus L. seeds were subjected to different temperature, light, salt, osmotic potential, pH value and burial depth treatments. The difference in germination response of two populations to the above abiotic environmental factors was used to study the fitness cost of nicosulfuron-resistance evolution in A. retroflexus. The aim is to find a powerful tool for weed control in the presence of evolutionary resistance selection. The results of this experiment showed that the germination rate and germination index in S population were generally higher than that in R population. When the salt stress was 80 mM, the water potential was -0.1 Mpa ~ -0.4 Mpa, and under strong acid and alkali conditions, the germination index in S population was prominently higher than that in R population (p<0.05). The delayed seed germination in R population indicated that its nicosulfuron resistance may be linked to seed biochemical compositions that altered seed germination dynamics. The resistant and sensitive biotype of A. retroflexus had differently favourable adaptability in diverse environments. Salt, osmotic potential and pH value are not the major constraints for A. retroflexus germination, however, A. retroflexus are strongly responsive to temperature, light and burial depth. Considering that seeds of A. retroflexus are unable to reach the soil surface beyond the depth of 6 cm, deep inversion tillage before sowing may be an effective and economical weed management tool for the control of nicosulfuron resistant A. retroflexus.
Assuntos
Amaranthus , Germinação , Amaranthus/crescimento & desenvolvimento , Amaranthus/fisiologia , Amaranthus/efeitos dos fármacos , Sementes/crescimento & desenvolvimento , Sementes/efeitos dos fármacos , Sementes/fisiologia , Herbicidas/farmacologia , Concentração de Íons de Hidrogênio , Compostos de Sulfonilureia/farmacologia , Temperatura , Resistência a Herbicidas , Luz , PiridinasRESUMO
In this study, the role of E3 ubiquitin ligase GmSNE3 in halosulfuron methyl (HSM) inhibiting soybean nodulation was investigated. GmSNE3 was strongly induced by HSM stress, and the overexpression of GmSNE3 significantly reduced the number of soybean nodules. Further investigation found that GmSNE3 could interact with a nodulation signaling pathway 1 protein (GmNSP1a) and GmSNE3 could mediate the degradation of GmNSP1a. Importantly, GmSNE3-mediated degradation of GmNSP1a could be promoted by HSM stress. Moreover, HSM stress and the overexpression of GmSNE3 resulted in a substantial decrease in the expression of the downstream target genes of GmNSP1a. These results revealed that HSM promotes the ubiquitin-mediated degradation of GmNSP1a by inducing GmSNE3, thereby inhibiting the regulatory effect of GmNSP1a on its downstream target genes and ultimately leading to a reduction in nodulation. Our findings will promote a better understanding of the toxic mechanism of herbicides on the symbiotic nodulation between legumes and rhizobia.
Assuntos
Regulação da Expressão Gênica de Plantas , Glycine max , Herbicidas , Proteínas de Plantas , Nodulação , Compostos de Sulfonilureia , Ubiquitina-Proteína Ligases , Glycine max/genética , Glycine max/metabolismo , Glycine max/química , Ubiquitina-Proteína Ligases/metabolismo , Ubiquitina-Proteína Ligases/genética , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Herbicidas/farmacologia , Nodulação/genética , Nodulação/efeitos dos fármacos , Regulação da Expressão Gênica de Plantas/efeitos dos fármacos , Compostos de Sulfonilureia/farmacologiaRESUMO
OBJECTIVE: Sulfonylureas (SUs) are still among the mostly prescribed antidiabetic drugs with an established mode of action: release of insulin from pancreatic ß-cells. In addition, effects of SUs on adipocytes by activation of the nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) have been described, which might explain their insulin-sensitizing potential observed in patients. However, there is a discrepancy between the impact of SUs on antidiabetic action and their rather moderate in vitro effect on PPARγ transcriptional activity. Recent studies have shown that some PPARγ ligands can improve insulin sensitivity by blocking PPARγ Ser-273 phosphorylation without having full agonist activity. It is unknown if SUs elicit their antidiabetic effects on adipocytes by inhibition of PPARγ phosphorylation. Here, we investigated if binding of SUs to PPARγ can interfere with PPARγ Ser-273 phosphorylation and determined their antidiabetic actions in vitro in primary human white adipocytes and in vivo in high-fat diet (HFD) obese mice. METHODS: Primary human white preadipocytes were differentiated in the presence of glibenclamide, glimepiride and PPARγ ligands rosiglitazone and SR1664 to compare PPARγ Ser-273 phosphorylation, glucose uptake and adipokine expression. Transcriptional activity at PPARγ was determined by luciferase assays, quantification of PPARγ Ser-273 phosphorylation was determined by Western blotting and CDK5 kinase assays. In silico modelling was performed to gain insight into the binding characteristics of SUs to PPARγ. HFD mice were administered SUs and rosiglitazone for 6 days. PPARγ Ser-273 phosphorylation in white adipose tissue (WAT), body composition, glucose tolerance, adipocyte morphology and expression levels of genes involved in PPARγ activity in WAT and brown adipose tissue (BAT) were evaluated. RESULTS: SUs inhibit phosphorylation of PPARγ at Ser-273 in primary human white adipocytes and exhibit a positive antidiabetic expression profile, which is characterized by up regulation of insulin-sensitizing and down regulation of insulin resistance-inducing adipokines. We demonstrate that SUs directly bind to PPARγ by in silico modelling and inhibit phosphorylation in kinase assays to a similar extend as rosiglitazone and SR1664. In HFD mice SUs reduce PPARγ phosphorylation in WAT and have comparable effects on gene expression to rosiglitazone. In BAT SUs increase UCP1 expression and reduce lipid droplets sizes. CONCLUSIONS: Our findings indicate that a part of SUs extra-pancreatic effects on adipocytes in vitro and in vivo is probably mediated via their interference with PPARγ phosphorylation rather than via classical agonistic activity at clinical concentrations.
Assuntos
Adipócitos , Hipoglicemiantes , PPAR gama , Compostos de Sulfonilureia , PPAR gama/metabolismo , Animais , Fosforilação , Hipoglicemiantes/farmacologia , Camundongos , Compostos de Sulfonilureia/farmacologia , Humanos , Adipócitos/metabolismo , Adipócitos/efeitos dos fármacos , Masculino , Serina/metabolismo , Camundongos Endogâmicos C57BL , Dieta Hiperlipídica/efeitos adversos , Células Cultivadas , Resistência à InsulinaRESUMO
BACKGROUND: The evolution of non-target site resistance (NTSR) to herbicides leads to a significant reduction in herbicide control of agricultural weed species. Detecting NTSR in weed populations prior to herbicide treatment would provide valuable information for effective weed control. While not all NTSR mechanisms have been fully identified, enhanced metabolic resistance (EMR) is one of the better studied, conferring tolerance through increased herbicide detoxification. Confirming EMR towards specific herbicides conventionally involves detecting metabolites of the active herbicide molecule in planta, but this approach is time-consuming and requires access to well-equipped laboratories. RESULTS: In this study, we explored the potential of using molecular biomarkers to detect EMR before herbicide treatment in black-grass (Alopecurus myosuroides). We tested the reliability of selected biomarkers to predict EMR and survival after herbicide treatments in both reference and 27 field-derived black-grass populations collected from sites across the UK. The combined analysis of the constitutive expression of biomarkers and metabolism studies confirmed three proteins, namely, AmGSTF1, AmGSTU2 and AmOPR1, as differential biomarkers of EMR toward the herbicides fenoxaprop-ethyl and mesosulfuron in black-grass. CONCLUSION: Our findings demonstrate that there is potential to use molecular biomarkers to detect EMR toward specific herbicides in black-grass without reference to metabolism analysis. However, biomarker development must include testing at both transcript and protein levels in order to be reliable indicators of resistance. This work is a first step towards more robust resistance biomarker development, which could be expanded into other herbicide chemistries for on-farm testing and monitoring EMR in uncharacterised black-grass populations. © 2024 The Authors. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Assuntos
Biomarcadores , Resistência a Herbicidas , Herbicidas , Poaceae , Propionatos , Compostos de Sulfonilureia , Herbicidas/farmacologia , Poaceae/efeitos dos fármacos , Poaceae/metabolismo , Poaceae/genética , Resistência a Herbicidas/genética , Compostos de Sulfonilureia/farmacologia , Propionatos/farmacologia , Propionatos/metabolismo , Biomarcadores/metabolismo , Proteínas de Plantas/metabolismo , Proteínas de Plantas/genética , Oxazóis/farmacologiaRESUMO
BACKGROUND: Shortawn foxtail (Alopecurus aequalis Sobol.) is a noxious weed in China. The resistance of A. aequalis developed rapidly due to the long-term application of acetolactate synthase (ALS)-inhibiting herbicides. Here, a suspected mesosulfuron-methyl-resistant A. aequalis population, Aa-R, was collected from a wheat field in China. RESULTS: A doseâresponse test showed that the Aa-R population has evolved a high level of resistance to mesosulfuron-methyl, and its growth was suppressed by imazamox, pyroxsulam and bispyribac-sodium. ALS gene sequence analysis revealed that a known resistance-related mutation (Pro-197-Thr) was present in the Aa-R population. Moreover, ALS gene overexpression was detected in the Aa-R population. The mesosulfuron-methyl resistance could be reversed by cytochrome P450 monooxygenase (CYP450) and glutathione S-transferase (GST) inhibitors. In addition, enhanced metabolism of mesosulfuron-methyl was detected in the Aa-R population compared with the susceptible population. NADPH-cytochrome P450 reductase and GST activities were strongly inducible in the Aa-R population. One CYP450 gene, CYP74A2, and one GST gene, GST4, were constitutively upregulated in the Aa-R population. Molecular docking results showed the binding affinity of CYP74A2 and GST4 for the tested ALS-inhibiting herbicides, respectively. CONCLUSION: This study confirmed that target-site resistance and non-target-site resistance involving CYP450 and GST were the main mechanisms involved in resistance in the mesosulfuron-methyl-resistant A. aequalis population.
Assuntos
Acetolactato Sintase , Resistência a Herbicidas , Herbicidas , Poaceae , Compostos de Sulfonilureia , Resistência a Herbicidas/genética , Compostos de Sulfonilureia/farmacologia , Acetolactato Sintase/genética , Acetolactato Sintase/metabolismo , Herbicidas/farmacologia , Poaceae/genética , Poaceae/efeitos dos fármacos , Poaceae/metabolismo , Sistema Enzimático do Citocromo P-450/genética , Sistema Enzimático do Citocromo P-450/metabolismo , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Glutationa Transferase/metabolismo , Glutationa Transferase/genética , Imidazóis/farmacologia , Regulação da Expressão Gênica de Plantas/efeitos dos fármacos , Mutação , Simulação de Acoplamento Molecular , Benzoatos , PirimidinasRESUMO
OBJECTIVE: To compare the effects of glimepiride and metformin on vascular reactivity, hemostatic factors and glucose and lipid profiles in patients with type 2 diabetes. METHODS: A prospective study was performed in 16 uncontrolled patients with diabetes previously treated with dietary intervention. The participants were randomized into metformin or glimepiride therapy groups. After four months, the patients were crossed over with no washout period to the alternative treatment for an additional four-month period on similar dosage schedules. The following variables were assessed before and after four months of each treatment: 1) fasting glycemia, insulin, catecholamines, lipid profiles and HbA1 levels; 2) t-PA and PAI-1 (antigen and activity), platelet aggregation and fibrinogen and plasminogen levels; and 3) the flow indices of the carotid and brachial arteries. In addition, at the end of each period, a 12-hour metabolic profile was obtained after fasting and every 2 hours thereafter. RESULTS: Both therapies resulted in similar decreases in fasting glucose, triglyceride and norepinephrine levels, and they increased the fibrinolytic factor plasminogen but decreased t-PA activity. Metformin caused lower insulin and pro-insulin levels and higher glucagon levels and increased systolic carotid diameter and blood flow. Neither metformin nor glimepiride affected endothelial-dependent or endothelial-independent vasodilation of the brachial artery. CONCLUSIONS: Glimepiride and metformin were effective in improving glucose and lipid profiles and norepinephrine levels. Metformin afforded more protection against macrovascular diabetes complications, increased systolic carotid artery diameter and total and systolic blood flow, and decreased insulin levels. As both therapies increased plasminogen levels but reduced t-PA activity, a coagulation process was likely still ongoing.
Assuntos
Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Artérias Carótidas/efeitos dos fármacos , /tratamento farmacológico , Hipoglicemiantes/farmacologia , Metformina/farmacologia , Compostos de Sulfonilureia/farmacologia , Glicemia/metabolismo , Artérias Carótidas/patologia , /sangue , Jejum/sangue , Hipoglicemiantes/uso terapêutico , Lipídeos/sangue , Tamanho do Órgão/efeitos dos fármacos , Estudos ProspectivosRESUMO
The use of herbicides is a common and intensive practice in no tillage systems. The herbicides can influence, directly or indirectly, the population of edaphic arthropods. Collembola is a group that functions as a bio-indicator of soil conditions. The degree of abundance and diversity of Collembola provides the level of soil disturbance provoked by agricultural practices. This experiment was designed to compare the influence of herbicides on the population fluctuation of Collembola in a no-till soil preparation system. The work was conducted in a non irrigated no-till area at the Núcleo Experimental de Ciências Agrárias of the Universidade Federal de Mato Grosso do Sul (UFMS), Campus de Dourados, in soil planted with corn as a surface covering, during the period of December, 2002 to December, 2003. The data were analyzed according to a completely randomized model, in a split plot design. The plots received four types of herbicides: glyphosate, atrazine, 2,4-D and nicosulfuron. A fifth plot did not receive any herbicide (control), for a total of five treatment types. The sub plots were represented by their collection times (10, 20, 30 and 40 days after the herbicide applications). Both the type of herbicide and the time of data sampling influenced the Collembola population fluctuaction. The treatments with atrazine and 2,4-D caused the most reduction of the population of Collembola, depending on the time of application.
No plantio direto o uso de herbicidas é uma prática comum e intensiva, que influencia direta ou indiretamente a população de artrópodes da mesofauna edáfica. O grau de abundância e diversidade de Collembola comumente é indicado para comprovar a extensão de distúrbios de várias práticas agrícolas, pois esse grupo serve como bioindicador das condições do solo. Esta pesquisa teve como objetivo comparar a influência de alguns herbicidas na flutuação populacional de Collembola, em solo sob o sistema de plantio direto. O trabalho foi realizado em uma área de plantio direto de sequeiro, do Núcleo Experimental de Ciências Agrárias da Universidade Federal de Mato Grosso do Sul (UFMS), Campus de Dourados, em latossolo roxo distroférrico com cobertura de milho, durante os meses de outubro de 2002 a janeiro de 2003. Os dados obtidos foram analisados segundo o modelo inteiramente casualizado constituído de tratamentos dispostos no esquema de parcelas subdivididas, onde as parcelas são representadas por uma testemunha mais quatro herbicidas: glifosate, atrazina, 2,4-D e nicosulfuron (totalizando cinco tratamentos) e as subparcelas pelas épocas de cada coleta (10, 20, 30 e 40 dias após aplicação dos herbicidas). Tanto os herbicidas testados quanto as épocas de coleta influenciaram a população de Collembola. Dependente do período de degradação dos herbicidas no solo, os tratamentos com 2,4-D, Atrazina, foram os que mais influenciaram a abundância de Collembola reduzindo sua população.
Assuntos
Animais , Artrópodes/efeitos dos fármacos , Atrazina/farmacologia , Glicina/análogos & derivados , Herbicidas/farmacologia , Piridinas/farmacologia , Compostos de Sulfonilureia/farmacologia , Glicina/farmacologiaRESUMO
Se plantea que debido a la heterogeneidad patogénica de la diabetes mellitus no insulino, se debe considerar que diferentes agentes farmacológicos serán necesarios para tratar con éxito la enfermedad, por lo cual se realiza una revisión bibliográfica de las líneas de tratamiento actuales y en perspectivas para esta compleja entidad. Las modalidades terpéuticas actuales incluyen 5 grupos de agentes esenciales: los inhibidores de las alfaglucosidasas intestinales, las sulfonilureas, las biguanidas, la insulina y el recién incorporado grupo de las tiazolidinedionas, que si se utilizan en los comienzos de la enfermedad o en pacientes con resistencia insulínica, pudieran retrasar o prevenir el desarrollo de ésta, y pueden interferir en la reducción progresiva de la función pancreática. Se expone un grupo importante de agentes farmacológicos, así como sus posibles mecanismos de acción, sobre los cuales se ha estado investigando, para ampliar e incrementar la terapéutica de la diabetes, entre los que se encuentran los análogos de la insulina, los agentes insulinomiméticos y los preparados orales de insulina, los agentes insulinotrópicos no sulfonilureas, los análogos de la amilina, los péptidos similares al glucagón, los antagonistas alfa-2 adrenérgicos, los moduladores del metabolismo de la glucosa y algunas sustancias de origen vegetal con posibles efectos hipoglucémicos
Assuntos
alfa-Glucosidases/antagonistas & inibidores , alfa-Glucosidases/farmacologia , Biguanidas/farmacologia , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/fisiopatologia , Diabetes Mellitus Tipo 2/terapia , Glucosidases/farmacologia , Insulina , Compostos de Sulfonilureia/farmacologia , Tiazóis/farmacologiaRESUMO
Recientemente se ha incorporado al arsenal terapéutico disponible para el tratamiento de la diabetes mellitus no insulinodependiente (DM-NID), un nuevo derivado sulfonilureico, la Glimepirida, llamada de tercera generación y que se utiliza en menores dosis que las ya existentes
Assuntos
Humanos , Diabetes Mellitus Tipo 2/tratamento farmacológico , Compostos de Sulfonilureia/uso terapêutico , Glibureto/farmacologia , Glibureto/uso terapêutico , Compostos de Sulfonilureia , Compostos de Sulfonilureia/farmacologiaRESUMO
Os hipoglicemiantes orais säo representados pelas sulfoniluréias e as biguanidas. As sulfoniluréias agem estimulando as células beta das ilhotas de Langerhans para a secreçäo de insulina e as biguanidas diminuindo a absorçäo de glicose ao nível do trato gastrointestinal. Dentre as sulfoniluréias temos as de primeira geraçäo com açäo mais prolongada e as de segunda geraçäo, 10 a 20 vezes mais potentes, mas com meia vida plasmática mais curta. Todas, com exceçäo da gliquidona, säo eliminadas por via renal, e assim contraindicadas em pacientes urêmicos. O uso das biguanidas está proibido nos E. U. A. e Inglaterra, mas no Brasil ainda estäo sendo comercializadas, mas devem ser usadas com cautela, pois existe o risco de acidose lática em pacientes predispostos a estados de anóxia. Os hipoglicemiantes orais estäo indicados nos pacientes portadores de diabetes mellitus tipo II, insulino independentes, que ainda têm capacidade pancreática para secretar insulina
Assuntos
Biguanidas/farmacologia , Diabetes Mellitus Tipo 2/tratamento farmacológico , Compostos de Sulfonilureia/farmacologia , Biguanidas/efeitos adversos , Biguanidas/metabolismo , Compostos de Sulfonilureia/efeitos adversosRESUMO
Las sulfonilureas, en particular las de segunda generación, son objeto de un creciente interés debido principalmente a que hoy en día se está comenzando a comprender la fisiopatología de la Diabetes Mellitus no Insulinodependiente (DMNID). La acción hipoglucemiante producida por estos fármacos a corto plazo es conocida desde hace tiempoñ sin embargo su acción a largo plazo no está totalmente clara. Varios son los mecanismos invocados, pero probablemente sólo dos de ellos están involucrados: la potenciación de la acción de la insulina a nivel periférico y la disminución de la producción hepática de glucosa. La potenciación de la acción de la insulina se realiza a nivel posreceptor, teniendo como principal consecuencia una disminución de la insulinorresistencia presente en los pacientes con DMNID. El mecanismo por el cual se produce la disminución de la producción hepatica de glucosa no está tan bien clarificado como el anterior. Sin embargo se ha observado una variación en unn metabolito intracelular, la fructosa 2,6-difosfato, que podría ser uno de los mecanismos subyacentes en los efectos posreceptor de aquellas sulfonilureas
Assuntos
Humanos , Diabetes Mellitus Tipo 2 , Compostos de Sulfonilureia/farmacologia , Glicemia/análise , Fígado , Insulina/metabolismoRESUMO
Based on the in vitro blockade of adrenal catecholamines release by sulfonylurea, we searched for an anti-stress activity of this drug. Stress-induced hyperglycemia and insulin inhibition were employed sadrenergic stress indicators. A standard dose of the oral sulfonylurea glipizide (200 micrograms/100 g), administered 15 min before a 1-h restraint stress to intact or 80 percent pancreatectomized rats, produced otalsuppression of the stress-induced hyperglycemia-hypoinsulinemia, an effect followed by a significant post-stress hypoglycemia of 1 h duration. The latter effect was elicited by all the sulfonylureas assayed. In the 80 percent pancreatectomized rats, glipizide nearly halved the increases in plasma catecholamines at 30 min of stress, but did not modify those attained at 60 min, when glycemia was decreasing and insulinemia was still increasing. Moreover, behavioral experiments in intact stressed rats showed that the adrenergic overt behavior inhibition caused by propranolol was not produced either by glipizide or insulin, reinforcing that glipizide affect was not mediated by catecholamine inhibition. These findings suggest a blockade of...
Assuntos
Animais , Masculino , Ratos , Hiperglicemia/etiologia , Insulina/sangue , Estresse Fisiológico/complicações , Compostos de Sulfonilureia/farmacologia , Análise de Variância , Catecolaminas/fisiologia , Hiperglicemia/terapia , Ratos Sprague-DawleyRESUMO
Glicose provoca a secreçao de insulina através do aumento da relaçao ATP/ADP no citoplasma das células beta. Isto leva ao bloqueio de canais de K+ sensíveis ao ATP (KATP), reduçao da saída deste cátion da célula, despolarizaçao celular, ativaçao da permeabilidade ao Ca2+ sensível à voltagem, entrada e acúmulo deste cátion nas células e consequente secreçao de insulina. O canal KATP parece ser composto por duas unidades distintas; uma delas, denominada Kir6,2, constitui o canal propriamente dito, por onde fluem as correntes de K+. A outra é o receptor de sulfoniluréias (SUR1), que é provida de sítios de ligaçao para o referido fármaco, para ATP, MgADP e diazoxida, atuando como unidade regulatória. Neste artigo, fazemos uma breve revisao da fisiologia dos canais KATP, considerando também sua importância na fisiopatologia do processo secretório.
Assuntos
Humanos , Trifosfato de Adenosina/farmacologia , Canais de Potássio , Glucose/farmacologia , Hiperinsulinismo/genética , Hiperinsulinismo/fisiopatologia , Insulina/metabolismo , Canais de Potássio/deficiência , Canais de Potássio/fisiologia , Hipoglicemiantes/farmacologia , Compostos de Sulfonilureia/farmacologiaRESUMO
El tratamiento farmacológico para los pacientes con diabetes mellitus tipo 2 se encuentra en su estado más maduro, con una base racional, con el principal objetivo de la prevención de la morbilidad y la mortalidad, lo que se encuentra considerado como el distintivo más importante en esta enfermedad. El tratamiento de los pacientes con diabetes mellitus tipo 2 con dieta ocurre en 12 por ciento, con hipoglucemiantes orales en 48 por ciento, con insulina en 36 por ciento, y 4 por ciento tienen un tratamiento combinado de hipoglucemiantes orales e insulina. Durante los últimos años ha habido una gran proliferación de nuevos medicamentos para el tratamiento de los pacientes con diabetes mellitus tipo 2. Estos productos ofrecen diferentes mecanismos de acción, lo que hace importante la individualización del tratamiento. Al momento de prescribir un hipoglucemiante oral debemos tener presente los efectos colaterales y las contraindicaciones